Pharmaids [PHARMAID] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison
Pharmaids
BSE
Loading...
Gujarat Themis
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Pharmaids wins in 4 metrics, Gujarat Themis wins in 14 metrics, with 0 ties. Gujarat Themis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pharmaids | Gujarat Themis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2,023.33 | 96.89 | Gujarat Themis |
| Price-to-Book Ratio | 3.71 | 17.39 | Pharmaids |
| Debt-to-Equity Ratio | 70.81 | 12.27 | Gujarat Themis |
| PEG Ratio | 23.66 | -3.07 | Gujarat Themis |
| EV/EBITDA | -17.36 | 65.59 | Pharmaids |
| Profit Margin (TTM) | -61.01% | 30.17% | Gujarat Themis |
| Operating Margin (TTM) | -90.28% | 33.14% | Gujarat Themis |
| EBITDA Margin (TTM) | N/A | 33.14% | N/A |
| Return on Equity | -19.58% | 19.64% | Gujarat Themis |
| Return on Assets (TTM) | -8.99% | 16.19% | Gujarat Themis |
| Free Cash Flow (TTM) | $-264.72M | $-251.22M | Gujarat Themis |
| 1-Year Return | 42.56% | 83.00% | Gujarat Themis |
| Price-to-Sales Ratio (TTM) | 10.23 | 29.28 | Pharmaids |
| Enterprise Value | $2.51B | $42.26B | Gujarat Themis |
| EV/Revenue Ratio | 11.75 | 28.58 | Pharmaids |
| Gross Profit Margin (TTM) | 47.39% | 77.71% | Gujarat Themis |
| Revenue per Share (TTM) | $6 | $14 | Gujarat Themis |
| Earnings per Share (Diluted) | $-3.70 | $4.09 | Gujarat Themis |
| Beta (Stock Volatility) | 0.38 | -0.40 | Gujarat Themis |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pharmaids vs Gujarat Themis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pharmaids | -0.43% | -0.58% | -7.46% | -8.45% | -12.03% | -16.22% |
| Gujarat Themis | 1.09% | 10.88% | 7.56% | 26.97% | 64.54% | 64.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pharmaids | 42.56% | 369.70% | 1,702.33% | 1,893.57% | 1,477.61% | 167.24% |
| Gujarat Themis | 83.00% | 83.00% | 83.00% | 83.00% | 83.00% | 83.00% |
Performance & Financial Health Analysis: Pharmaids vs Gujarat Themis
| Metric | PHARMAID | GUJTHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.19B | ₹43.28B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,939 | 137,612 |
| 90 Day Avg. Volume | 9,637 | 213,338 |
| Last Close | ₹62.00 | ₹400.60 |
| 52 Week Range | ₹31.90 - ₹87.46 | ₹208.00 - ₹405.00 |
| % from 52W High | -29.11% | -1.09% |
| All-Time High | ₹87.46 (Nov 11, 2024) | ₹405.00 (Aug 01, 2025) |
| % from All-Time High | -29.11% | -1.09% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.43% | -0.08% |
| Quarterly Earnings Growth | 0.43% | -0.32% |
| Financial Health | ||
| Profit Margin (TTM) | -0.61% | 0.30% |
| Operating Margin (TTM) | -0.90% | 0.33% |
| Return on Equity (TTM) | -0.20% | 0.20% |
| Debt to Equity (MRQ) | 70.81 | 12.27 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹16.72 | ₹22.80 |
| Cash per Share (MRQ) | ₹0.61 | ₹1.15 |
| Operating Cash Flow (TTM) | ₹-278,094,000 | ₹969.95M |
| Levered Free Cash Flow (TTM) | ₹-107,766,000 | ₹487.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Pharmaids vs Gujarat Themis
| Metric | PHARMAID | GUJTHEM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2,023.33 | 96.89 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 23.66 | -3.07 |
| Price to Sales (TTM) | 10.23 | 29.28 |
| Price to Book (MRQ) | 3.71 | 17.39 |
| Market Capitalization | ||
| Market Capitalization | ₹2.19B | ₹43.28B |
| Enterprise Value | ₹2.51B | ₹42.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.75 | 28.58 |
| Enterprise to EBITDA | -17.36 | 65.59 |
| Risk & Other Metrics | ||
| Beta | 0.38 | -0.40 |
| Book Value per Share (MRQ) | ₹16.72 | ₹22.80 |
Financial Statements Comparison: Pharmaids vs Gujarat Themis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PHARMAID | GUJTHEM |
|---|---|---|
| Revenue/Sales | ₹66.64M | ₹377.36M |
| Cost of Goods Sold | ₹35.06M | ₹83.50M |
| Gross Profit | ₹31.58M | ₹293.86M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-60.16M | ₹148.11M |
| EBITDA | ₹-53.69M | ₹173.87M |
| Pre-Tax Income | ₹-71.71M | ₹160.87M |
| Income Tax | ₹-18.56M | ₹40.89M |
| Net Income (Profit) | ₹-53.15M | ₹119.98M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PHARMAID | GUJTHEM |
|---|---|---|
| Cash & Equivalents | ₹21.45M | ₹116.94M |
| Total Current Assets | ₹223.07M | ₹519.73M |
| Total Current Liabilities | ₹287.15M | ₹205.60M |
| Long-Term Debt | ₹331.19M | ₹296.36M |
| Total Shareholders Equity | ₹550.42M | ₹2.48B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹446.50M | ₹411.30M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PHARMAID | GUJTHEM |
|---|---|---|
| Operating Cash Flow | ₹-1.10M | N/A |
| Capital Expenditures | ₹0 | N/A |
| Free Cash Flow | ₹2.39M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PHARMAID | GUJTHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,939 | 137,612 |
| Average Daily Volume (90 Day) | 9,637 | 213,338 |
| Shares Outstanding | 35.27M | 108.97M |
| Float Shares | 5.46M | 30.70M |
| % Held by Insiders | 0.93% | 0.72% |
| % Held by Institutions | 0.00% | 0.01% |
Dividend Analysis & Yield Comparison: Pharmaids vs Gujarat Themis
| Metric | PHARMAID | GUJTHEM |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |